comparemela.com

Latest Breaking News On - Samsung bioepis - Page 1 : comparemela.com

Italy Probes Novartis and Roche Over Eye Drug Competition

Italy's antitrust regulator will investigate several companies including Novartis over anti-competitive practices related to an eye drug.

Samsung bioepisRoche controlled genentech

Updates on Aflibercept Biosimilar Approvals and BPCIA Litigation | Goodwin

Updates on Aflibercept Biosimilar Approvals and BPCIA Litigation | Goodwin
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

United statesWest virginiaThomass kleehSamsung bioepisMylan bioconCo ltdBiocon biologics incJudicial panel on multidistrict litigationRegeneron pharmaceutical incMylan pharmaceuticals incAmgen incMylan pharmaceuticalsBiocon biologicsRegeneron pharmaceuticalTemporary restrainingJudicial panel

Italy opens antitrust case against Novartis, Roche and others, claiming collusion to delay biosim launch

Italy opens antitrust case against Novartis, Roche and others, claiming collusion to delay biosim launch
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Roche genentechSamsung bioepisSamsung biologicsItalian competition authority

Health News Highlights: Drugmaker Under Scrutiny, Bird Flu Outbreak, Diabetes Trials Halted

Recent health news includes drugmaker WuXi AppTec working with Chinese military scientists on altitude sickness treatments, FDA halting Biomea's diabetes trials due to liver toxicity, and a bird flu outbreak in Minnesota. Additionally, an antitrust probe into pharmaceutical companies over an eye drug and Novo Nordisk facing generic challenges in China are reported.

United kingdomUnited statesSamsung bioepisEli lillyDrug administrationJuul labNovo nordiskPeople liberation armyWuxi apptecLiberation armyRoche controlled genentechEli lilly alzheimer

Samsung Bioepis to Present Post-hoc Analysis of Phase 3

Post-hoc analysis of Phase 3 study to highlight transfusion avoidance results of SB12 compared to reference eculizumab-treated groups INCHEON, Korea, May .

Eculizumab biosimilarYounsoo kimSamsung bioepisJihyun hanPaola russoHyejin kimHus laboratory monitoringLifecycle safety team leader at samsung bioepisEuropean hematology associationLaboratory monitoringSamsung bioepis co ltdEuropean unionEuropean medicines agencyEuropean commissionAlexion pharmaceuticalsHybrid congress

vimarsana © 2020. All Rights Reserved.